Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

ALPHA 1 EFFECTIVE AGAINST HEPATITIS B

Aug. 30, 1991

PROFIT TAKING ON THE LIPOSOME CO. STOCK

Aug. 30, 1991

AUTOIMMUNE RESPONSES TO GM-CSF

Aug. 30, 1991

DEPRENYL GETS RIGHTS TO CANCER TREATMENT

Aug. 29, 1991

CANCER FIGHTER MADE MORE POTENT

Aug. 29, 1991

EARLY SUCCESS AGAINST MD DEFECT

Aug. 29, 1991

FOUR BIOTECH STOCKS POST BIG GAINS

Aug. 29, 1991

VERTEX UNDERWRITERS EXERCISE OPTION

Aug. 29, 1991

APPLIED BIO BUYS LABORATORY BUSINESS

Aug. 29, 1991

APPEALS COURT UPHOLDS COLLAGEN RULING

Aug. 29, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...